Lisa is the Vice Chair of the Zucker Institute for Innovation Commercialization, and a Fellow of the Centre for Health Leadership and Enterprise at the Cambridge Judge Business School of the University of Cambridge. She is a co-author of the book, From Breakthrough to Blockbuster: The Business of Biotechnology, published by Oxford University Press in 2022, and named a Financial Times Top Business Title.

Lisa was the founding CEO of Genmab, one of Europe’s most successful biotech companies. During her leadership, the company completed a record-setting IPO, raised over a billion dollars, and created novel medicines for cancer and Multiple Sclerosis. The company was Scrip’s Biotech Company of the Year, and she received the Watson Helix Award for leadership in innovation and citizenship. She has been inducted into the New Jersey High Tech Hall of Fame.

Lisa pioneered a Women’s Walking and Weight Loss Wellness program when she was Chair of Volunteers in Medicine, a large free and charitable clinic for the medically underserved. Seeing that >90% of the women patients had heart disease risk factors, Lisa designed a program combining health education, pedometers, modest incentives, peer support, and a focus on patient accomplishments to build self-esteem.

Lisa graduated with honors from Mount Holyoke College and received a Ph.D. from Princeton University, where she has served as a member of the faculty. Also a Certified Sommelier, she received the expert-level Diploma in Wines with merit from the Wine and Spirits Education Trust, and has conducted wine education events at universities in Europe and the U.S.